AdaptHealth股票討論區

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

$AdaptHealth(AHCO.US)$ 跌跌不休！

$AdaptHealth(AHCO.US)$2018年上市，2019年開始產生營收，近3年平均增速爲78%，其中2022年增速21%。營業利潤高速增長到2021年，受毛利率大幅下滑影響2022年下滑15.6%。淨利潤2021年扭虧達到1.58億，2022年大幅下滑54%到0.73億。
2023Q1營收增長5.4%，營業利潤大幅下滑49%，淨利潤下滑60.5%，本季度連毛利率都成負的了。
目前市盈率31.8，市盈率TTM已經達到55.3，缺乏吸引力。

Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%,$EDGIO(EGIO.US)$ +13.5%,$Lemonade(LMND.US)$ +10.7%,$Desktop Metal(DM.US)$ +8.5%,$ShockWave Medical(SWAV.US)$ +8.2%,$Pubmatic(PUBM.US)$ +8.1%,$Olaplex(OLPX.US)$ +7%,$Vivid Seats(SEAT.US)$ +6.4%,$Noble(NE.US)$ +6.3%,$艾斯本科技(AZPN.US)$ +5.4%,$艾倫建材(AAON.US)$ +5%,$Hudbay Minerals(HBM.US)$ +5%,$Vivint Smart Home(VVNT.US)$ +4.9%,$Vivint Smart Home(VVNT.US)$ +4...